CAPITAL IMPACT ADVISORS, LLC – Arrowhead Pharmaceuticals, Inc. Transaction History
CAPITAL IMPACT ADVISORS, LLC portfolio value:
$680,000
portfolio value
CAPITAL IMPACT ADVISORS, LLC quarter portfolio value change:
-6.13%
quarter
Arrowhead Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +14.35% | 2.79K shares | -5K | $33.05 | 22.23K |
| Q2 2022 | share | Increase | +22.04% | 3.51K shares | -48K | $35.21 | 19.44K |
| Q1 2022 | share | Increase | +309.27% | 12.04K shares | 475K | $45.99 | 15.93K |
| Q4 2021 | share | Increase | 0.00% | 3.89K shares | 258K | $67.35 | 3.89K |
| Q1 2021 | share | Decrease | -100.00% | -88.18K shares | -6.76M | $66.31 | 0 |
| Q4 2020 | share | Decrease | -50.51% | -90K shares | -907K | $76.73 | 88.18K |
| Q3 2020 | share | 0.00% | 0 shares | -23K | $43.06 | 178.18K | |
| Q2 2020 | share | Increase | +110.78% | 93.64K shares | 5.26M | $43.19 | 178.18K |
| Q1 2020 | share | Increase | 0.00% | 84.53K shares | 2.43M | $28.77 | 84.53K |